Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Kezar Life Sciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 104 | 82 | −22 |
| Shares | 56.9M | 55.5M | −1.40M (−2.5%) |
| Value | $139.4M | $66.0M | −$73.4M (−52.6%) |
New holders (6)
Institutions that held Kezar Life Sciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| International Biotechnology Trust PLC | 703,825 | $830.5K | 0.28% |
| Squarepoint Ops LLC | 152,925 | $182.0K | 0.00% |
| Pale Fire Capital SE | 68,851 | $81.9K | 0.01% |
| SG Americas Securities, LLC | 32,841 | $39.0K | 0.00% |
| RVW Wealth, LLC | 23,765 | $28.3K | 0.00% |
| JustInvest LLC | 13,422 | $16.0K | 0.00% |
Sold out (28)
Institutions that held Kezar Life Sciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.